Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter
Discovery & Development Drug Discovery
The Microbiome Miner

| Angus Stewart | 9 min read

Water is the giver of life, but could it be a giver of untold medicines too?

Manufacture Small Molecules

Getting to Grips With mRNA

| Catherine Jomary | 4 min read

Walking through the mRNA manufacturing process – and its many challenges.

Business & Regulation Standards & Regulation

Stem Cell Therapy’s Unwelcome Surprise

| Angus Stewart | 9 min read

After years of progress in the courts, could one verdict in California give unproven stem cell clinics an unwelcome boost?

Register to personalize your newsfeed
Create Account

Latest Articles

 Manufacture Advanced Medicine

Cell and Gene Champions Speak Up

| Angus Stewart

Get a sharp perspective on the cell and gene status quo in The Medicine Maker 2022 supplement on advanced medicine
Manufacture Small Molecules

It’s Time to Calculate the Carbon Footprint of Pharmaceutical Products

| Bailey Risteen | 6 min read

BASF has put substantial effort into reducing carbon emissions. A key aspect of their strategy lies in extracting and acting upon the right data.
Business & Regulation Digital Technologies

There’s Nothing Artificial About AI’s Potential in Pharma Research

| Avi Kulkarni | 3 min read

Can AI realistically transform data management in pharma? Yes. And it’s already begun.
Manufacture Small Molecules

Fighting the Resistance – to Malaria

| Stephanie Sutton | 4 min read

Widely-used antimalarial drugs are losing efficacy. What are researchers doing to prevent that?
Manufacture Process Control

The Human Cost of Poor Practice

| Rob Coker | 2 min read

A growing number of deaths linked to pediatric medicines prompts the WHO to investigate “unacceptable” levels of APIs.
Discovery & Development Clinical Trials

Why Sex Matters in Drug Development

| Emma Banks | 3 min read

Why conversations on gender in drug development must go further.
Business & Regulation Profession

What’s Your Job?

| Angus Stewart | 4 min read

What did switching from client to constructor teach a seasoned biotech professional?
Discovery & Development Formulation

Goodbye, Moisture. Hello, mRNA

| Stephanie Sutton | 2 min read

Could dry vaccines help improve global access to the latest vaccine technologies?
Discovery & Development Clinical Trials

Positive Opinion for Regeneron’s Libtayo

| Rob Coker | 3 min read

Regeneron Pharmaceuticals’ Israel Lowy explains how a positive CHMP opinion can become good news for cancer patients
Manufacture Small Molecules

From Bread to Blood

| Rob Coker | 4 min read

How critical anti-cancer drugs can be sustainably developed from genetically engineered baker’s yeast.
All Articles

Upcoming Events

-
4th Gene Therapy Analytical Development Summit

Boston, MA, USA

This year’s summit returns in-person to Boston to reunite 300+ analytical experts in innovative biotech, pharma and...
-
6th CAR-TCR Summit Europe

London, UK

Join the 6th CAR-TCR Summit Europe in London this February to drive next-generation CAR-TCR approaches and connect with...
Event
-
4th Gene Therapy Analytical Development Summit

Boston, MA, USA

This year’s summit returns in-person to Boston to reunite 300+ analytical experts in innovative biotech, pharma and academia to continue to develop resilient, long-lasting and robust analytical tools to enhance the safety, quality and efficacy of gene therapy products.

More information

Event
-
6th CAR-TCR Summit Europe

London, UK

Join the 6th CAR-TCR Summit Europe in London this February to drive next-generation CAR-TCR approaches and connect with the trailblazers of this industry. Advance multiplexed engineering, armouring and combination approaches with accelerated manufacturing turnaround times to enhance clinical performance fit for early line treatment.

More information

All Events

Sister Publications

You might be interested in our Sister Publications:

Latest White Papers

Nitrosamines Risk Mitigation: The critical role of excipients and supplier qualification

| Contributed by DFE Pharma GmbH & Co. KG

Ploughshare® Mixer for batch operation in pharmaceutical production: well-established all-rounder

| Contributed by Lodige

Accelerate Your Cell Line Development Process for Commercial Production

| Contributed by Sartorius

Direct-to-Patient (DtP) Clinical Trials – Using RTSM Systems to Overcome Supply Challenges

| Contributed by 4G Clinical

All White Papers

Webinars on Demand

Manufacture Advanced Medicine

To Freeze or not to freeze - challenges and innovations in cell therapy logistics

| Sponsored by World Courier

In recent years, Advanced Therapy Medicinal Products (ATMPs) have evolved into a promising and highly hoped-for medical approach to cure a broad spectrum of diseases.
Discovery & Development Ingredients

Umicore roundtable on cross-coupling catalysis

Umicore PMC wishes to leverage the annual online discussion with The Medicine Maker to review the latest developments of palladium based cross-coupling catalysts technology.
Discovery & Development Drug Discovery

Tired of Manual Staining? Meet the LabSat® Research Platform

| Sponsored by Epredia

Want to learn how to achieve IHC assays in 30 minutes and multiplex assays in 2.5 hours?

All Webinars

Most popular articles

1. Manufacture Advanced Medicine

The Pros and Cons of Lentiviral and Adeno-Associated Viral Vectors

| Suparna Sanyal | 5 min read

Demand for gene therapies is rising, so all the more reason to better understand the properties of their delivery devices
2. Discovery & Development Drug Discovery

Fresh Hope for ADC Development

| Rob Coker | 6 min read

Historic challenges in ADC Development have not thwarted some players
3. Business & Regulation Standards & Regulation

Stem Cell Therapy’s Unwelcome Surprise

| Angus Stewart | 9 min read

After years of progress in the courts, could one verdict in California give unproven stem cell clinics an unwelcome boost?
4. Discovery & Development Drug Discovery

D is for Decolonize: Sitting Down With Luis Pizarro

| Angus Stewart | 10 min read

The Drugs for Neglected Diseases initiative has a new leader – and he’s on a mission to redefine global health for an egalitarian, postcolonial world
5. Business & Regulation Digital Technologies

There’s Nothing Artificial About AI’s Potential in Pharma Research

| Avi Kulkarni | 3 min read

Can AI realistically transform data management in pharma? Yes. And it’s already begun.
Discovery & Development
Drug Discovery

The Microbiome Miner

| Angus Stewart | 9 min read

Water is the giver of life, but could it be a giver of untold medicines too?

Clinical Trials

Why Sex Matters in Drug Development

| Emma Banks | 3 min read

Why conversations on gender in drug development must go further.
Formulation

Goodbye, Moisture. Hello, mRNA

| Stephanie Sutton | 2 min read

Could dry vaccines help improve global access to the latest vaccine technologies?
Manufacture
Small Molecules

It’s Time to Calculate the Carbon Footprint of Pharmaceutical Products

| Bailey Risteen | 6 min read

BASF has put substantial effort into reducing carbon emissions. A key aspect of their strategy lies in extracting and acting upon the right data.
Advanced Medicine

Cell and Gene Champions Speak Up

| Angus Stewart

Get a sharp perspective on the cell and gene status quo in The Medicine Maker 2022 supplement on advanced medicine
Small Molecules

Getting to Grips With mRNA

| Catherine Jomary | 4 min read

Walking through the mRNA manufacturing process – and its many challenges.
Business & Regulation
Digital Technologies

There’s Nothing Artificial About AI’s Potential in Pharma Research

| Avi Kulkarni | 3 min read

Can AI realistically transform data management in pharma? Yes. And it’s already begun.
Standards & Regulation

Stem Cell Therapy’s Unwelcome Surprise

| Angus Stewart | 9 min read

After years of progress in the courts, could one verdict in California give unproven stem cell clinics an unwelcome boost?
Profession

What’s Your Job?

| Angus Stewart | 4 min read

What did switching from client to constructor teach a seasoned biotech professional?
Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register

October Issue of The Medicine Maker